Nephros NEPH
NASDAQ NEPH
$3.31 +0.24 (+7.82%)
At close: Nov 12, 2026 · 4:00 PM EST

Nephros (NEPH) Gains (Losses) on Sale of Assets & Investments (2012 - 2013)

Updated

Nephros (NEPH) posted Non Operating Investment Income of $3,000 for FY2013, down 94.5% from $55,000 in FY2012.

Analysis

Nephros (NEPH) Gains (Losses) on Sale of Assets & Investments (2012 - 2013) Analysis & Trends

  • Business Quant data shows NEPH's Non Operating Investment Income at $55,000 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn -
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn -
3 Danaher 163.29 Bn 142.96 Bn 3.84 Bn -
4 Intuitive Surgical 152.47 Bn 132.89 Bn 2.08 Bn -
5 Medtronic 131.95 Bn 97.47 Bn 6.34 Bn -
6 Stryker 119.59 Bn 105.78 Bn 4.25 Bn -
7 Boston Scientific 64.18 Bn 59.61 Bn 3.43 Bn -
8 Edwards Lifesciences 60.93 Bn 44.24 Bn 1.35 Bn -
9 Medline 52.61 Bn 49.74 Bn 1.93 Bn 13.00 Mn
10 Nephros 35.98 Mn 17.32 Mn 3.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 1,000.00
Mar 31, 2013 2,000.00
Dec 31, 2012 55,000.00
API Access

Nephros Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NEPH&period=max&api_key=YOUR_API_KEY